Skip to main content

Table 1 Stable Clonotypes.

From: Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells

Clonotypes

Ex Vivo

IPP Expand

DONOR: ND001

2007

2008

2007

2008

CALW         SR         ELG

52

34

13

21

CALWE         A         ELG

14

28

11

14

CALWE         RK         QELG

<3

<3

6

3

CALWEV      RK         LG

3

6

5

9

CALWEV               QELG

4

<3

5

4

CALWE         T      QELG

<3

<3

11

21

CALWE         TE   QELG

<3

<3

6

10

N

165

158

151

239

DONOR: ND006

    

CALWEV               QELG

11

13

11

13

CALWE         AK      ELG

<3

9

5

10

CALWE         A      QELG

11

6

5

12

CALWEV      R         ELG

<3

4

6

4

N

156

206

186

287

DONOR: ND019

    

CALWEV      D         ELG

28

36

36

23

CALWE      PQ      QELG

10

5

4

7

CALWEV               QELG

7

9

4

7

CALWEV   R            ELG

6

3

3

8

CALWE      A         QELG

8

8

9

5

CALWE      IE      QELG

<3

<3

6

5

N

163

256

166

246

  1. Vγ2 chain clonotypes (CDR3 region) are shown for donors ND001, ND006 and ND019. For each clonotype, we show the proportion of all Vγ2 chains represented by that clonotype for specimens collected in 2007 or 2008. Clonotype abundance for ex vivo and post-expansion samples are shown. The N values represent the total number of Vγ2 chain DNA sequences obtained for each specimen.